OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease
James D. Chalmers, Ralph Kettritz, Brice Korkmaz
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16

Showing 16 citing articles:

Pathophysiology and genomics of bronchiectasis
Lídia Perea, Rosa Faner, James D. Chalmers, et al.
European Respiratory Review (2024) Vol. 33, Iss. 173, pp. 240055-240055
Open Access | Times Cited: 6

Growing from common ground: nontuberculous mycobacteria and bronchiectasis
Eva Van Braeckel, Cédric Bosteels
European Respiratory Review (2024) Vol. 33, Iss. 173, pp. 240058-240058
Open Access | Times Cited: 5

Challenges in treating patients with comorbid asthma and bronchiectasis
Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera, et al.
Respiratory Medicine (2025), pp. 107957-107957
Closed Access

Isolation, synthesis and structure–activity relationships of gallotannin derivatives as cathepsin C inhibitor
Hongying Liao, Liang-Mou Kuo, Wei-Ting Chen, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130133-130133
Closed Access

Neutrophils and NETs in kidney disease
Daigo Nakazawa, Sakiko Masuda, Yuka Nishibata, et al.
Nature Reviews Nephrology (2025)
Closed Access

Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target
Marcus Mall, Jane C. Davies, Scott H. Donaldson, et al.
European Respiratory Review (2024) Vol. 33, Iss. 173, pp. 240001-240001
Open Access | Times Cited: 3

Targeting cathepsin C ameliorates murine acetaminophen-induced liver injury
Jessica Raith, Malte Bachmann, Sina Gonther, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3029-3042
Open Access | Times Cited: 2

Pharmacological inhibition of cathepsin S and of NSPs-AAP-1 (a novel, alternative protease driving the activation of neutrophil serine proteases)
Roxane Domain, Seda Seren, Uwe Jerke, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116114-116114
Open Access | Times Cited: 1

Identification of novel indolinone derivatives as CTSC inhibitors to treat inflammatory bowel disease by modulating inflammatory factors
Xing Chen, Yan Lou, Feilong Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116914-116914
Closed Access | Times Cited: 1

Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in COPD?
Daniel C. Belz, Nirupama Putcha, Patricia Alupo, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 11, pp. 1300-1307
Closed Access | Times Cited: 1

Mast cells are not essential for pubertal mammary gland branching.
Simran S. Kapoor, Jimmy Marsden, Clara M. Munz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Bronchiectasis and neutrophil dominant inflammation
Bruce K. Rubin
Pediatric Pulmonology (2024)
Closed Access

Page 1

Scroll to top